BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35205388)

  • 1. Developing Non-Human Primate Models of Inherited Retinal Diseases.
    Seah I; Goh D; Chan HW; Su X
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for inherited retinal diseases: progress and possibilities.
    Hu ML; Edwards TL; O'Hare F; Hickey DG; Wang JH; Liu Z; Ayton LN
    Clin Exp Optom; 2021 May; 104(4):444-454. PubMed ID: 33689657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene editing prospects for treating inherited retinal diseases.
    Benati D; Patrizi C; Recchia A
    J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer therapeutic options for inherited retinal diseases: Gene and cell replacement therapy.
    Battu R; Ratra D; Gopal L
    Indian J Ophthalmol; 2022 Jul; 70(7):2316-2325. PubMed ID: 35791112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited retinal diseases: Linking genes, disease-causing variants, and relevant therapeutic modalities.
    Schneider N; Sundaresan Y; Gopalakrishnan P; Beryozkin A; Hanany M; Levanon EY; Banin E; Ben-Aroya S; Sharon D
    Prog Retin Eye Res; 2022 Jul; 89():101029. PubMed ID: 34839010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Foundation Fighting Blindness Plays an Essential and Expansive Role in Driving Genetic Research for Inherited Retinal Diseases.
    Shaberman B; Durham T
    Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31284566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes of people with inherited retinal conditions toward gene editing technology.
    Hoffman-Andrews L; Mazzoni R; Pacione M; Garland-Thomson R; Ormond KE
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00803. PubMed ID: 31190471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-syndromic inherited retinal diseases in Poland: Genes, mutations, and phenotypes.
    Tracewska AM; Kocyła-Karczmarewicz B; Rafalska A; Murawska J; Jakubaszko-Jabłónska J; Rydzanicz M; Stawiński P; Ciara E; Lipska-Ziętkiewicz BS; Khan MI; Cremers FPM; Płoski R; Chrzanowska KH
    Mol Vis; 2021; 27():457-465. PubMed ID: 34321860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An optometrist's guide to the top candidate inherited retinal diseases for gene therapy.
    O'Hare F; Edwards TL; Hu ML; Hickey DG; Zhang AC; Wang JH; Liu Z; Ayton LN
    Clin Exp Optom; 2021 May; 104(4):431-443. PubMed ID: 33689629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited Retinal Diseases and Retinal Organoids as Preclinical Cell Models for Inherited Retinal Disease Research.
    Ashworth KE; Weisbrod J; Ballios BG
    Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases.
    Hansen S; McClements ME; Corydon TJ; MacLaren RE
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Worldwide Disease Prevalence and Genetic Prevalence of Inherited Retinal Diseases and Variant Interpretation Considerations.
    Hanany M; Shalom S; Ben-Yosef T; Sharon D
    Cold Spring Harb Perspect Med; 2024 Feb; 14(2):. PubMed ID: 37460155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine and Feline Models of Inherited Retinal Diseases.
    Petersen-Jones SM; Komáromy AM
    Cold Spring Harb Perspect Med; 2024 Feb; 14(2):. PubMed ID: 37217283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in research on pathogenic genes and gene therapy for inherited retinal diseases].
    Zhu L; Cao C; Sun J; Gao T; Liang X; Nie Z; Ji Y; Jiang P; Guan M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):118-123. PubMed ID: 28186610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.
    Sanjurjo-Soriano C; Kalatzis V
    Neural Plast; 2018; 2018():5056279. PubMed ID: 29853845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases.
    Chuang K; Fields MA; Del Priore LV
    Yale J Biol Med; 2017 Dec; 90(4):635-642. PubMed ID: 29259527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene and cell-based therapies for inherited retinal disorders: An update.
    Sengillo JD; Justus S; Tsai YT; Cabral T; Tsang SH
    Am J Med Genet C Semin Med Genet; 2016 Dec; 172(4):349-366. PubMed ID: 27862925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygosity mapping and targeted sanger sequencing reveal genetic defects underlying inherited retinal disease in families from pakistan.
    Maria M; Ajmal M; Azam M; Waheed NK; Siddiqui SN; Mustafa B; Ayub H; Ali L; Ahmad S; Micheal S; Hussain A; Shah ST; Ali SH; Ahmed W; Khan YM; den Hollander AI; Haer-Wigman L; Collin RW; Khan MI; Qamar R; Cremers FP
    PLoS One; 2015; 10(3):e0119806. PubMed ID: 25775262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases.
    Xue K; MacLaren RE
    Expert Opin Investig Drugs; 2020 Oct; 29(10):1163-1170. PubMed ID: 32741234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges to Gene Editing Approaches in the Retina.
    Bonillo M; Pfromm J; Fischer MD
    Klin Monbl Augenheilkd; 2022 Mar; 239(3):275-283. PubMed ID: 35316854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.